| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A concomitant radiotherapy (RT) and chemotherapy (CT) associating vinorelbine (NVB), ifosfamide (IFM), and carboplatin (CBDCA) in non-small cell lung carcinomas (NSCLC)
|
Bonnet, D
|
|
1998
|
21 |
S1 |
p. S57-
1 p.
|
artikel
|
| 2 |
Adjuvant chemotherapy of non-small cell lung cancer (NSCLC)
|
Le Chevalier, T
|
|
1998
|
21 |
S1 |
p. S26-
1 p.
|
artikel
|
| 3 |
A literature-based qualitative and quantitative overview of chemotherapy versus best supportive care for stage IV non-small cell lung cancer (NSCLC)
|
Paesmans, M
|
|
1998
|
21 |
S1 |
p. S24-
1 p.
|
artikel
|
| 4 |
A literature-based qualtative and quantitative overview of chemotherapy for malignant mesothelioma
|
Paesmans, M
|
|
1998
|
21 |
S1 |
p. S24-
1 p.
|
artikel
|
| 5 |
A multicentric case-control study of the major risk factors for lung cancer in Europe
|
Simonato, L
|
|
1998
|
21 |
S1 |
p. S37-S38
2 p.
|
artikel
|
| 6 |
Analysis of extrathoracic metastases in patients with non-small cell lung cancer at presentation
|
Kačar, V
|
|
1998
|
21 |
S1 |
p. S57-
1 p.
|
artikel
|
| 7 |
A.N.I.T.A. (Adjuvant Navelbine International Trialist Association). A possible solution to the unresolved issues in adjuvant therapy for resectable non-small cell lung cancer (NSCLC)
|
Douillard, JY
|
|
1998
|
21 |
S1 |
p. S27-
1 p.
|
artikel
|
| 8 |
A novel prospective for lung cancer treatment: gemcitabine, a chemotherapeutic drug, as a radiosensitizer
|
Casamassima, F
|
|
1998
|
21 |
S1 |
p. S23-
1 p.
|
artikel
|
| 9 |
A phase III randomized study comparing, in non-metastatic unresectable non-small cell lung cancer (NSCLC) responding to chemotherapy (CT), further CT to loco-regional irradiation (RT)
|
Sculier, JP
|
|
1998
|
21 |
S1 |
p. S29-
1 p.
|
artikel
|
| 10 |
A phase I II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated concomitant boost irradiation in inoperable non-small cell lung cancer
|
Viallet, J
|
|
1998
|
21 |
S1 |
p. S30-S31
2 p.
|
artikel
|
| 11 |
A phase II study of a modified cisplatin and gemcitabine regimen in advanced non-small cell lung cancer (NSCLC): preliminary results
|
Gonzalez-Martin, A
|
|
1998
|
21 |
S1 |
p. S49-
1 p.
|
artikel
|
| 12 |
A phase II study of cisplatin-gemcitabine in locally advanced and metastatic non-small cell lung cancer
|
Vázquez, F
|
|
1998
|
21 |
S1 |
p. S53-S54
2 p.
|
artikel
|
| 13 |
A phase II study of navelbine® (NVB) and cisplatin (CDDP) in advanced non-small cell lung cancer stage IIIb–IV (NSCLC): interim results
|
Deppermann, KM
|
|
1998
|
21 |
S1 |
p. S55-
1 p.
|
artikel
|
| 14 |
A phase II study of navelbine® (NVB) and cisplatin (CDDP) in advanced non-small cell lung cancer stage IIIb-IV (NSCLC): interim results
|
Depperman, KM
|
|
1998
|
21 |
S1 |
p. S35-S36
2 p.
|
artikel
|
| 15 |
A phase II trial of radio-chemotherapy with daily carboplatin, after induction chemotherapy (cisplatin and vinorelbine), in locally advanced non-small-cell lung cancer (LANSCLC): final analysis
|
Bardet, E
|
|
1998
|
21 |
S1 |
p. S27-
1 p.
|
artikel
|
| 16 |
A phase II trial of vinorelbine and cisplatin in previously intreated inoperable non-small cell lung cancer
|
Shih, JF
|
|
1998
|
21 |
S1 |
p. S54-
1 p.
|
artikel
|
| 17 |
A possible approach to in vitro testing of chemosensitivity of human lung tumours
|
Vesely, P
|
|
1998
|
21 |
S1 |
p. S39-
1 p.
|
artikel
|
| 18 |
Atypical bronchial carcinoid tumor (ABCT): retrospective analysis of a single-institution series of 22 cases
|
Ceresoli, G
|
|
1998
|
21 |
S1 |
p. S40-
1 p.
|
artikel
|
| 19 |
Author index
|
|
|
1998
|
21 |
S1 |
p. S65-S69
5 p.
|
artikel
|
| 20 |
Avicidin® therapy: high dose systemic radiation with tumor regressions in phase I II clinical trials of antibody pretargeting
|
|
|
1998
|
21 |
S1 |
p. S22-
1 p.
|
artikel
|
| 21 |
Beta-carotene, vitamin-A and vitamin-C levels in patients with lung cancer
|
Behera, D
|
|
1998
|
21 |
S1 |
p. S20-
1 p.
|
artikel
|
| 22 |
Bronchoscopy in coexisting lung cancer and tuberculosis
|
Jakovic, R
|
|
1998
|
21 |
S1 |
p. S47-
1 p.
|
artikel
|
| 23 |
Carboplatin and etoposide for small cell lung cancer in very elderly patients
|
Berzinec, P
|
|
1998
|
21 |
S1 |
p. S52-
1 p.
|
artikel
|
| 24 |
Carboplatin and gemcitabine chemotherapy for malignant pleural mesothelioma (MPM): a phase II study of the GSTPV
|
Aversa, SML
|
|
1998
|
21 |
S1 |
p. S53-
1 p.
|
artikel
|
| 25 |
Cardiospecific troponin T—the evaluation of its usefulness for staging the heart muscle's injury in the course of a high-dose epirubicin chemotherapy
|
Kozielski, J
|
|
1998
|
21 |
S1 |
p. S45-
1 p.
|
artikel
|
| 26 |
Chemoprevention for lung cancer
|
Martinet, Y
|
|
1998
|
21 |
S1 |
p. S5-S6
2 p.
|
artikel
|
| 27 |
Chemoprevention of lung cancer by long-term nicotine replacement for highly addicted tobacco consumers
|
Kunze, K
|
|
1998
|
21 |
S1 |
p. S21-
1 p.
|
artikel
|
| 28 |
Cisplatin and vinorelbine in advanced non-small cell lung carcinoma at the Instituto Nacional de Cancerología of Mexico
|
Alcedo, J
|
|
1998
|
21 |
S1 |
p. S50-S51
2 p.
|
artikel
|
| 29 |
Cisplatin-etoposide versus cisplatin-epirubicin for small cell lung cancer
|
D, Kocić
|
|
1998
|
21 |
S1 |
p. S54-
1 p.
|
artikel
|
| 30 |
Cisplatin resistance
|
Akiyama, S
|
|
1998
|
21 |
S1 |
p. S28-
1 p.
|
artikel
|
| 31 |
Cisplatin sensitivity and resistance in lung cancer
|
Saijo, N
|
|
1998
|
21 |
S1 |
p. S8-S9
2 p.
|
artikel
|
| 32 |
Clinical drug resistance in cancer
|
Pirker, R
|
|
1998
|
21 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 33 |
Clinical relevance of p53 protein expression in non-small cell lung cancer (NSCLC) patients (pts)
|
Jassem, E
|
|
1998
|
21 |
S1 |
p. S23-
1 p.
|
artikel
|
| 34 |
Combination of cisplatin, ifosfamide and vinorelbine in phase II trial in advanced non-small cell lung cancer (NSCLC)
|
Barón, FJ
|
|
1998
|
21 |
S1 |
p. S51-S52
2 p.
|
artikel
|
| 35 |
Combination of gemcitabine (G), ifosfamide (I) and vinorelbine (N) for advanced non-small cell lung cancer (NSCLC): a phase II study
|
Castellano, D
|
|
1998
|
21 |
S1 |
p. S35-
1 p.
|
artikel
|
| 36 |
Comparative analysis of certain parameters in different infiltrative lung changes of malignant and inflammatory etiology
|
Kunosic, J
|
|
1998
|
21 |
S1 |
p. S45-S46
2 p.
|
artikel
|
| 37 |
Comparison among thoracoscopy and the other methods in diagnosis of malignant pleural effusions
|
Plutinský, J
|
|
1998
|
21 |
S1 |
p. S60-
1 p.
|
artikel
|
| 38 |
Comparison of split-course therapy with conventional fractionated, palliative radiotherapy for NSCLC
|
Lewandowska, A
|
|
1998
|
21 |
S1 |
p. S57-S58
2 p.
|
artikel
|
| 39 |
Concomitant brain radiotherapy and gemcitabine + CCNV in brain relapses of lung cancer
|
Santoro, A
|
|
1998
|
21 |
S1 |
p. S58-
1 p.
|
artikel
|
| 40 |
Concurrent irradiation in induction therapy prior to surgery for locally-advanced non-small cell lung cancer (NSCLC)
|
Kris, MG
|
|
1998
|
21 |
S1 |
p. S26-
1 p.
|
artikel
|
| 41 |
Continuous infusion vinorelbine (VRL) for advanced nonsmall cell lung cancer (NSCLC). A phase I II study
|
Carabantes, F
|
|
1998
|
21 |
S1 |
p. S34-
1 p.
|
artikel
|
| 42 |
CORDIS tamponada — initial sign of lung adenocarcinoma
|
Videnovic-Ivanov, J
|
|
1998
|
21 |
S1 |
p. S61-
1 p.
|
artikel
|
| 43 |
Cost-effective diagnosis and staging of non-small cell lung cancers
|
Osada, H
|
|
1998
|
21 |
S1 |
p. S19-
1 p.
|
artikel
|
| 44 |
CT of brain and clinical evaluation in the initial staging of non-small cell lung cancer (NSCLC)
|
Yilmaz, MU
|
|
1998
|
21 |
S1 |
p. S47-S48
2 p.
|
artikel
|
| 45 |
Current and future trends in lung cancer mortality in the Czech Republic
|
Zatloukal, P
|
|
1998
|
21 |
S1 |
p. S2-S3
2 p.
|
artikel
|
| 46 |
Cyfra 21-1 in the diagnosis of lung cancer
|
Prisadov, G
|
|
1998
|
21 |
S1 |
p. S48-
1 p.
|
artikel
|
| 47 |
Delayed complicatins of combination therapy for lung cancer
|
Krutilina, NI
|
|
1998
|
21 |
S1 |
p. S60-
1 p.
|
artikel
|
| 48 |
Deregulation of some tissue-specific neuroendocrine markers in lung cancer
|
Vachtenheim, J
|
|
1998
|
21 |
S1 |
p. S38-S39
2 p.
|
artikel
|
| 49 |
Diagnostic difficulties of malignant pleural effusions
|
Fijalkowski, M
|
|
1998
|
21 |
S1 |
p. S43-S44
2 p.
|
artikel
|
| 50 |
Diet and lung cancer in Rosario, Argentina
|
Dip, O
|
|
1998
|
21 |
S1 |
p. S20-
1 p.
|
artikel
|
| 51 |
Distribution of inflammatory syndrome indicators among malignant, tuberculous and pneumonic lung infiltrates
|
Mitic, T
|
|
1998
|
21 |
S1 |
p. S41-S42
2 p.
|
artikel
|
| 52 |
Diurnal variations of serum erythropoietin (s-EPO) levels in patients with lung cancer
|
Petruzelka, L
|
|
1998
|
21 |
S1 |
p. S24-
1 p.
|
artikel
|
| 53 |
Dose intensity phase I II trial with ifosfamide, carboplatin, etoposide, and vincristine combined with filgastrim (CEV-Ifo + G) in patients with small-cell lung cancer (SCLC)
|
Hanauske, A-R
|
|
1998
|
21 |
S1 |
p. S62-S63
2 p.
|
artikel
|
| 54 |
Drug resistance in lung cancer: future perspectives
|
Huber, H
|
|
1998
|
21 |
S1 |
p. S28-
1 p.
|
artikel
|
| 55 |
Drug resistance mechanisms in lung cancer specimens
|
Filipits, M
|
|
1998
|
21 |
S1 |
p. S28-
1 p.
|
artikel
|
| 56 |
Duplicite malignant tumours in lung cancer patients
|
Pešek, M
|
|
1998
|
21 |
S1 |
p. S41-
1 p.
|
artikel
|
| 57 |
Early diagnosis of lung cancer: historical background and perspectives
|
Sculier, J-P
|
|
1998
|
21 |
S1 |
p. S3-S4
2 p.
|
artikel
|
| 58 |
Early intensification chemotherapy for the treatment of small cell lung cancer
|
Rosti, G
|
|
1998
|
21 |
S1 |
p. S62-
1 p.
|
artikel
|
| 59 |
Early rehabilitation of patients after thoracotomy
|
Mujovic, N
|
|
1998
|
21 |
S1 |
p. S59-S60
2 p.
|
artikel
|
| 60 |
Efficacy and safety of vinorelbine in elderly patients (aged > 70 years) with advanced NSCLC
|
Mattioli, R
|
|
1998
|
21 |
S1 |
p. S50-
1 p.
|
artikel
|
| 61 |
Endobronchial BRT HDR in NSLC. Valuation of early clinical results of particular fractions. Preliminary report
|
Kabarowski, R
|
|
1998
|
21 |
S1 |
p. S56-S57
2 p.
|
artikel
|
| 62 |
Endobronchial metastasis of malignant melanoma — case report
|
Kovkarova, E
|
|
1998
|
21 |
S1 |
p. S59-
1 p.
|
artikel
|
| 63 |
Endobronchial treatment of lung cancer
|
van Zandwijk, N
|
|
1998
|
21 |
S1 |
p. S14-S16
3 p.
|
artikel
|
| 64 |
Evaluation of lymph nodes in lung cancer by endoscopic ultrasonography (EUS) and computed tomography (CT)
|
Kozlowski, M
|
|
1998
|
21 |
S1 |
p. S19-
1 p.
|
artikel
|
| 65 |
Explorative thoracotomy in lung cancer patients
|
Fiala, P
|
|
1998
|
21 |
S1 |
p. S41-
1 p.
|
artikel
|
| 66 |
Expression analysis of the tumor susceptibility gene 101 (TSG101) in lung cancer
|
Werner, TG
|
|
1998
|
21 |
S1 |
p. S47-
1 p.
|
artikel
|
| 67 |
Expression of MN-tumor associated antigen in resected non-small cell lung cancer (NSCLC): a new biomarker of in situ and invasive disease
|
Vermylen, P
|
|
1998
|
21 |
S1 |
p. S22-
1 p.
|
artikel
|
| 68 |
Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial
|
Georgoulias, V
|
|
1998
|
21 |
S1 |
p. S33-
1 p.
|
artikel
|
| 69 |
Gemcitabine and cisplatin as a first line therapy in non-small cell lung cancer
|
Pes̆ek, M
|
|
1998
|
21 |
S1 |
p. S33-
1 p.
|
artikel
|
| 70 |
Gemcitabine and vinorelbine in advanced non-small cell lung cancer: a phase II trial
|
Vázquez, F
|
|
1998
|
21 |
S1 |
p. S36-
1 p.
|
artikel
|
| 71 |
Gemcitabine in locally advanced and metastatic non-small cell lung cancer (NSCLC): The central European phase II study
|
Zatloukal, P
|
|
1998
|
21 |
S1 |
p. S31-
1 p.
|
artikel
|
| 72 |
Gemcitabine in non-small cell lung cancer—experience in 30 patients
|
Kowalski, DM
|
|
1998
|
21 |
S1 |
p. S51-
1 p.
|
artikel
|
| 73 |
Gemcitabine monotherapy in the elderly patient with advanced non-small cell lung cancer (NSCLC): preliminary results of a tuscany multicentric phase II study
|
Antonuzzo, A
|
|
1998
|
21 |
S1 |
p. S48-
1 p.
|
artikel
|
| 74 |
Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung cancer
|
Šalagovič, J
|
|
1998
|
21 |
S1 |
p. S47-
1 p.
|
artikel
|
| 75 |
HDR endoluminal brachytherapy in lung cancer
|
Prévost, B
|
|
1998
|
21 |
S1 |
p. S56-
1 p.
|
artikel
|
| 76 |
High dose farmorubicin versus farmorubicin plus carboplatin in advanced non-small cell lung carcinoma: preliminary report
|
Kozielski, J
|
|
1998
|
21 |
S1 |
p. S51-
1 p.
|
artikel
|
| 77 |
Ifosfamide, epirubicin and vincristine alternating with oral etoposide plus cisplatin in small cell lung cancer (SCLC). A phase II trial
|
Rodrígeuz, CA
|
|
1998
|
21 |
S1 |
p. S62-
1 p.
|
artikel
|
| 78 |
Immunobiology of solid tumors: clinical significance of cytokine secretion
|
Fischer, JR
|
|
1998
|
21 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 79 |
Immunophenotypes of peripheral lymphocytes in lung cancer
|
Pešek, M
|
|
1998
|
21 |
S1 |
p. S39-
1 p.
|
artikel
|
| 80 |
Impact of smoking intervention on lung function—4-year-study
|
Wimberger, F
|
|
1998
|
21 |
S1 |
p. S44-
1 p.
|
artikel
|
| 81 |
Impact of smoking intervention on lung function — 4-year-study
|
Wimberger, F
|
|
1998
|
21 |
S1 |
p. S22-
1 p.
|
artikel
|
| 82 |
Impact of type and stage of lung cancer on tumor markers' blood levels
|
Pešek, M
|
|
1998
|
21 |
S1 |
p. S39-S40
2 p.
|
artikel
|
| 83 |
Incidence and clinical significance of anaemia during chemoradiotherapy for advanced non-small cell lung cancer
|
Zemanová, M
|
|
1998
|
21 |
S1 |
p. S61-
1 p.
|
artikel
|
| 84 |
Induction chemotherapy (ind CT) followed by concomitant chemoradiotherapy (CXRT) for stage III non-small cell lung cancer
|
Vokes, EE
|
|
1998
|
21 |
S1 |
p. S29-
1 p.
|
artikel
|
| 85 |
Induction chemotherapy in stage IIIA B non-small cell lung cancer (NSCLC): response rates, pattern of relapse, survival times
|
Müller, A
|
|
1998
|
21 |
S1 |
p. S25-
1 p.
|
artikel
|
| 86 |
Infection-related deaths in patients (pts) treated for small cell lung cancer (SCLC) in the years 1980–1994
|
Remiszewski, P
|
|
1998
|
21 |
S1 |
p. S46-
1 p.
|
artikel
|
| 87 |
Infections in patients suffering from lung and mediastinal malignancy
|
Čertíková, G
|
|
1998
|
21 |
S1 |
p. S44-S45
2 p.
|
artikel
|
| 88 |
Intensive chemotherapy in the management of small cell lung cancer
|
Thatcher, N
|
|
1998
|
21 |
S1 |
p. S63-
1 p.
|
artikel
|
| 89 |
Interaction between genetic and environmental factors in lung carcinogenesis: a molecular epidemiology case control study
|
Puntoni, R
|
|
1998
|
21 |
S1 |
p. S37-
1 p.
|
artikel
|
| 90 |
Interferon-alpha and retinoid acid maintenance therapy for small cell lung cancer following high-dose chemotherapy (ICE) and growth factor
|
Rutosalainen, T
|
|
1998
|
21 |
S1 |
p. S63-
1 p.
|
artikel
|
| 91 |
Is alveolar macrophages' chloroacetate esterase a marker of squamous cell lung carcinoma?
|
Zunic, SS
|
|
1998
|
21 |
S1 |
p. S43-
1 p.
|
artikel
|
| 92 |
Is alveolar macrophages' chloroacetate esterase a marker of squamous cell lung carcinoma?
|
zunic, SS
|
|
1998
|
21 |
S1 |
p. S20-
1 p.
|
artikel
|
| 93 |
Is chemosensitivity a predictive factor for radiosensitivity in non-small cell lung cancer? Lesson from European Lung Cancer working party phase III randomised trial
|
Baumöhl, J
|
|
1998
|
21 |
S1 |
p. S41-
1 p.
|
artikel
|
| 94 |
Local control of tracheo-bronchial carcinoma using high-frequency thermocoagulation (HFT)
|
Homasson, JP
|
|
1998
|
21 |
S1 |
p. S55-S56
2 p.
|
artikel
|
| 95 |
Longer survival of women with lung cancer
|
Radzikowska, E
|
|
1998
|
21 |
S1 |
p. S44-
1 p.
|
artikel
|
| 96 |
Lung cancer among men and women in Lithuania
|
Jackevicius, A
|
|
1998
|
21 |
S1 |
p. S45-
1 p.
|
artikel
|
| 97 |
Lung cancer: impact of mental conditions
|
Semotánová, M
|
|
1998
|
21 |
S1 |
p. S45-
1 p.
|
artikel
|
| 98 |
Lung cancer in women
|
Kubík, A
|
|
1998
|
21 |
S1 |
p. S37-
1 p.
|
artikel
|
| 99 |
Lung carcinoma and old tuberculous lesions: coexistence or coincidence. Analysis of operation samples
|
Radosavljevic, T
|
|
1998
|
21 |
S1 |
p. S45-
1 p.
|
artikel
|
| 100 |
Main features of lung cancer and pulmonary tuberculosis concomitance: an analysis
|
Pavlovic, S
|
|
1998
|
21 |
S1 |
p. S42-S43
2 p.
|
artikel
|
| 101 |
Mapping of the Pas1 locus by population based study
|
Manenti, G
|
|
1998
|
21 |
S1 |
p. S39-
1 p.
|
artikel
|
| 102 |
Molecular epidemiology of lung cancer
|
Bonassi, S
|
|
1998
|
21 |
S1 |
p. S38-
1 p.
|
artikel
|
| 103 |
Molecular strategies for therapy of small cell lung cancer
|
Stahel, R
|
|
1998
|
21 |
S1 |
p. S6-S8
3 p.
|
artikel
|
| 104 |
MRP and LRP
|
Scheper, RJ
|
|
1998
|
21 |
S1 |
p. S28-
1 p.
|
artikel
|
| 105 |
Multicentric randomized phase II study with gemcitabine (GEM) plus cisplatin (CDDP) in patients with stage IIIB-IV NSCLC
|
Ricci, S
|
|
1998
|
21 |
S1 |
p. S48-
1 p.
|
artikel
|
| 106 |
Multidisciplinary approach to microcytoma of the lung
|
Ruggieri, M
|
|
1998
|
21 |
S1 |
p. S61-S62
2 p.
|
artikel
|
| 107 |
Multimodality therapy for locally advanced stage IIIA-B non-small cell lung cancer (NSCLC)
|
Zharkov, V
|
|
1998
|
21 |
S1 |
p. S58-S59
2 p.
|
artikel
|
| 108 |
Multimodality therapy (MMT) in stage IIIA non-small cell lung cancer (NSCLC): long term results and pattern of relapse in resected patients
|
Ceresoli, G
|
|
1998
|
21 |
S1 |
p. S40-
1 p.
|
artikel
|
| 109 |
Multiple lung cancer
|
Krejbich, F
|
|
1998
|
21 |
S1 |
p. S42-
1 p.
|
artikel
|
| 110 |
Navelbine, ifosfamide and cisplatin (NIP) combination as a treatment of non-small cell lung cancer, first Czech experience
|
Čertíková, G
|
|
1998
|
21 |
S1 |
p. S51-
1 p.
|
artikel
|
| 111 |
Navelbine + ifosfamide + cisplatin (NIP) in locally advanced NSCLC
|
Gottfried, M
|
|
1998
|
21 |
S1 |
p. S25-
1 p.
|
artikel
|
| 112 |
Neoadjuvant chemoradiotherapy for stage III non-small cell lung cancer
|
Friedel, G
|
|
1998
|
21 |
S1 |
p. S26-S27
2 p.
|
artikel
|
| 113 |
Neo-adjuvant chemotherapy followed by surgery and/or radiotherapy in patients with stage IIIB non-small cell lung cancer (NSCLC), preliminary data
|
Schramel, F
|
|
1998
|
21 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 114 |
Neo-adjuvant chemotherapy (NCT) in non-small cell lung cancer (NSCLC): hope for progress
|
Depierre, A
|
|
1998
|
21 |
S1 |
p. S24-S25
2 p.
|
artikel
|
| 115 |
Neoadjuvant therapy in locoregionally advanced non-small cell lung cancer (NSCLC) in the course of 7 years
|
Spelda, S
|
|
1998
|
21 |
S1 |
p. S54-S55
2 p.
|
artikel
|
| 116 |
Non-cisplatin-based chemotherapy for advanced non-small cell lung cancer (NSCLC). A phase II study with vinorelbine (VNR) and gemcitabine (GEM)
|
Rodríguez, R
|
|
1998
|
21 |
S1 |
p. S49-
1 p.
|
artikel
|
| 117 |
Noninvasive diagnostic work-up correlated with operative findings in non-small lung cell cancer (NSCLC) patients
|
Ioan, A
|
|
1998
|
21 |
S1 |
p. S56-
1 p.
|
artikel
|
| 118 |
Overexpression of vascular endothelial growth factor (VEGF) and receptor in micropapillomatosis, a preneoplastic bronchial lesion
|
Vermylen, P
|
|
1998
|
21 |
S1 |
p. S23-
1 p.
|
artikel
|
| 119 |
Paclitaxel and carboplatin in combination with gemcitabine (PCG): a phase I–II trial in non-small cell lung cancer (NSCLC)
|
Favaretto, A
|
|
1998
|
21 |
S1 |
p. S52-
1 p.
|
artikel
|
| 120 |
Phase I II study of gemcitabine (GEM) plus vinorelbine (NAV) in patients with stage IIIB-IV non-small cell lung cancer (NSCLC)
|
Lorusso, V
|
|
1998
|
21 |
S1 |
p. S49-S50
2 p.
|
artikel
|
| 121 |
Phase I II trial of docetaxel (D) and carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
|
Giannakakis, Th
|
|
1998
|
21 |
S1 |
p. S31-S32
2 p.
|
artikel
|
| 122 |
Phase I II trial of paclitaxel (P), carboplatin (C), and irinotecan (CPT-11), in advanced or metastatic non-small-cell lung cancer (NSCLC)
|
Socinski, MA
|
|
1998
|
21 |
S1 |
p. S32-S33
2 p.
|
artikel
|
| 123 |
Phase II trial of gemcitabine as second line therapy for non-small cell lung cancer (NSCLC)
|
Gillenwater, HH
|
|
1998
|
21 |
S1 |
p. S49-
1 p.
|
artikel
|
| 124 |
Phase II trial of i.v. navelbine (NVB) and cisplatin (CDDP) in inoperable locally advanced or disseminated NSCLC
|
Goedhals, L
|
|
1998
|
21 |
S1 |
p. S34-
1 p.
|
artikel
|
| 125 |
Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) combination in metastatic non-small cell lung cancer (NSCLC)
|
Kakolyris, S
|
|
1998
|
21 |
S1 |
p. S32-
1 p.
|
artikel
|
| 126 |
Photodetection and treatment of in situ cancers
|
Philippe, V
|
|
1998
|
21 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 127 |
Pre- and post-graduate physician's education in smoking cessation as cancer prevention
|
Kozák, JT
|
|
1998
|
21 |
S1 |
p. S21-S22
2 p.
|
artikel
|
| 128 |
Preliminary results of weekly chemotherapy with paclitaxel (T) and carboplatin (CBP) in patients (P) with advanced lung cancer (ALC)
|
Schneider, C-P
|
|
1998
|
21 |
S1 |
p. S54-
1 p.
|
artikel
|
| 129 |
Prognostic factors and long-term results in patients with NSCLC treated with definitive radiotherapy
|
Lewandowska, A
|
|
1998
|
21 |
S1 |
p. S57-
1 p.
|
artikel
|
| 130 |
Projections of lung cancer mortality in the European Union until the year 2010
|
E, Kramárová
|
|
1998
|
21 |
S1 |
p. S18-S19
2 p.
|
artikel
|
| 131 |
Prolonged oral etoposide in combination with intravenous cisplatin (oral EP) for non-small cell lung cancer (NSCLC)
|
Park, K
|
|
1998
|
21 |
S1 |
p. S34-S35
2 p.
|
artikel
|
| 132 |
Prophylactic brain irradiation (PBI) in patients suffering from small cell lung cancer
|
Dokulil, J
|
|
1998
|
21 |
S1 |
p. S60-
1 p.
|
artikel
|
| 133 |
Protoadjuvant chemotherapy prior to radiotherapy
|
Gatzemeier, U
|
|
1998
|
21 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 134 |
Radioactive colloid gold 198 Au in combination therapy of small-cell lung cancer
|
Yaskevich, LS
|
|
1998
|
21 |
S1 |
p. S60-S61
2 p.
|
artikel
|
| 135 |
Radiographic presentation of malignomas, specific infiltrates and pneumonic processes without effusions
|
Nedeljković, B
|
|
1998
|
21 |
S1 |
p. S42-
1 p.
|
artikel
|
| 136 |
Radiotherapy combined with daily platinum chemotherapy in inoperable non-small-cell lung cancer (NSCLC)
|
Raymond, S
|
|
1998
|
21 |
S1 |
p. S30-
1 p.
|
artikel
|
| 137 |
Radiotherapy of small cell lung cancer (SCLC)
|
Gregor, A
|
|
1998
|
21 |
S1 |
p. S9-S10
2 p.
|
artikel
|
| 138 |
Recent trends in smoking and lung cancer in Finland
|
Hakulinen, T
|
|
1998
|
21 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 139 |
Relation between age and the frequency of SCLC metastasis
|
Adžić, T
|
|
1998
|
21 |
S1 |
p. S44-
1 p.
|
artikel
|
| 140 |
Salvage treatment with paclitaxel and gemcitabine for patients with non-small cell lung cancer after cisplatin- or docetaxelbased chemotherapy: a multicenter phase II study
|
Androulakis, N
|
|
1998
|
21 |
S1 |
p. S36-
1 p.
|
artikel
|
| 141 |
Scientific data on chemoprevention of lung cancer by nicotine replacement
|
Kunze, U
|
|
1998
|
21 |
S1 |
p. S21-
1 p.
|
artikel
|
| 142 |
Screening trial for lung cancer by helical CT scan
|
Nakabayashi, T
|
|
1998
|
21 |
S1 |
p. S42-
1 p.
|
artikel
|
| 143 |
Second-line treatment of non-small cell lung carcinomas with vinorelbine and ifosfamide: preliminary results of a phase II trial of the Greek Cooperative Group for Lung Cancer
|
Papadakis, E
|
|
1998
|
21 |
S1 |
p. S36-S37
2 p.
|
artikel
|
| 144 |
Sequential chemo-radiation-therapy in stage IIIB NSCLC patients: a phase II study
|
Silvano, G
|
|
1998
|
21 |
S1 |
p. S29-S30
2 p.
|
artikel
|
| 145 |
Small bowel metastases in non-small cell lung cancer (NSCLC). A case report after radical resection and a review of 218 autopsies in a cohort of 733 NSCLC-patients (pts) in all stages
|
Stenbygaard, LE
|
|
1998
|
21 |
S1 |
p. S40-S41
2 p.
|
artikel
|
| 146 |
Small cell lung cancer. New drugs, any progress?
|
Postmus, P
|
|
1998
|
21 |
S1 |
p. S11-S13
3 p.
|
artikel
|
| 147 |
Stage migration and prognostic impact of the 5th edition of the TNM classification for lung cancer
|
Bülzebruck, H
|
|
1998
|
21 |
S1 |
p. S19-
1 p.
|
artikel
|
| 148 |
Stents and multimodal therapy of malignant tracheobronchial stenoses
|
Kolek, V
|
|
1998
|
21 |
S1 |
p. S57-
1 p.
|
artikel
|
| 149 |
Strategy of smoking control in the Czech Republic
|
Kr̆íz̆, J
|
|
1998
|
21 |
S1 |
p. S18-
1 p.
|
artikel
|
| 150 |
Surgery and adjuvant chemotherapy in the treatment of small cell lung cancer
|
Zharkov, V
|
|
1998
|
21 |
S1 |
p. S59-
1 p.
|
artikel
|
| 151 |
Surgical aspects of second primary lung carcinoma
|
Zharkov, V
|
|
1998
|
21 |
S1 |
p. S58-
1 p.
|
artikel
|
| 152 |
Surgical resection for non-small cell lung cancer—the impact of chemotherapy
|
Ginsberg, RJ
|
|
1998
|
21 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 153 |
Surgical treatment of patients with non-small cell lung cancer (NSCLC) with synchronous metastases to the central nervous system (CNS)
|
Furmanik, F
|
|
1998
|
21 |
S1 |
p. S55-
1 p.
|
artikel
|
| 154 |
Taxotere in combination with cisplatinum in inoperable nonsmall cell lung cancer (NSCLC)
|
Le Chevalier, T
|
|
1998
|
21 |
S1 |
p. S37-
1 p.
|
artikel
|
| 155 |
The concomitance of lung cancer and pulmonary tuberculosis. A case report
|
Kuruc, V
|
|
1998
|
21 |
S1 |
p. S46-
1 p.
|
artikel
|
| 156 |
The heavy smoker and lung cancer
|
Kubík, A
|
|
1998
|
21 |
S1 |
p. S21-
1 p.
|
artikel
|
| 157 |
The impact of chemotherapy on quality of life (QoL) in advanced non-small cell lung cancer. Results of a multicenter phase-III study
|
Paccagnella, A
|
|
1998
|
21 |
S1 |
p. S52-S53
2 p.
|
artikel
|
| 158 |
The perspective of local control for non-small cell lung cancer
|
Turrisi III, AT
|
|
1998
|
21 |
S1 |
p. S16-S18
3 p.
|
artikel
|
| 159 |
The politics of tobacco
|
Gray, N
|
|
1998
|
21 |
S1 |
p. S1-S2
2 p.
|
artikel
|
| 160 |
Therapeutic approach in old age lung cancer patients
|
Zivkovic, J
|
|
1998
|
21 |
S1 |
p. S59-
1 p.
|
artikel
|
| 161 |
Therapeutic landmarks in the TNM staging for non-small cell lung cancer
|
Grunenwald, D
|
|
1998
|
21 |
S1 |
p. S10-S11
2 p.
|
artikel
|
| 162 |
Therapy of NSCLC by radiotherapy and chemotherapy
|
Hořenková,
|
|
1998
|
21 |
S1 |
p. S60-
1 p.
|
artikel
|
| 163 |
The role of ultrasonography in diagnosis of lung cancer dissemination
|
Stević, R
|
|
1998
|
21 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 164 |
The unilateral opacified hemithorax: a sonographic challenge
|
Goerg, C
|
|
1998
|
21 |
S1 |
p. S43-
1 p.
|
artikel
|
| 165 |
Treatment after R1-resection of NSCLC: is adjuvant radiation the best therapy?
|
Reinmuth, N
|
|
1998
|
21 |
S1 |
p. S58-
1 p.
|
artikel
|
| 166 |
Tumor chemopreventive agent N-acetyl-l-cysteine inhibits the cysteine protease cathepsin B
|
Kr̆epela, E
|
|
1998
|
21 |
S1 |
p. S38-
1 p.
|
artikel
|
| 167 |
Vinorelbine + DDP: neoadjuvant CT in IIIB NSCLC
|
Michetti, G
|
|
1998
|
21 |
S1 |
p. S50-
1 p.
|
artikel
|
| 168 |
Vinorelbine/gemcitabine in advanced non-small-cell lung cancer: a phase I trial
|
Krajnik, G
|
|
1998
|
21 |
S1 |
p. S35-
1 p.
|
artikel
|
| 169 |
Vinorelbine monotherapy in advanced non-small cell lung cancer
|
Beinert, T
|
|
1998
|
21 |
S1 |
p. S31-
1 p.
|
artikel
|
| 170 |
Vinorelbine plus cisplatin and concurrent radiotherapy in non-small cell lung cancer
|
Zatloukal, P
|
|
1998
|
21 |
S1 |
p. S30-
1 p.
|
artikel
|
| 171 |
Vinorelbine (VNR)-cisplatin (C) combination neoadjuvant chemotherapy in stage IIIB non-small cell lung cancer (NSCLC): results after 2 years
|
Cigolari, S
|
|
1998
|
21 |
S1 |
p. S53-
1 p.
|
artikel
|
| 172 |
Vinorelbine (VNR) plus best supportive care (BSC) vs. BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (PTS). Results of a phase III randomized trial
|
Gridelli, C
|
|
1998
|
21 |
S1 |
p. S33-S34
2 p.
|
artikel
|
| 173 |
Weekly vinorelbine with monthly cisplatin: preliminary results obtained with this regimen in advanced non-small-cell lung cancer
|
Costa, A
|
|
1998
|
21 |
S1 |
p. S52-
1 p.
|
artikel
|
Tijdschrift beschrijving